Alpha memo: resveratrol exercise training mice translation boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The 'surprising' framing could be slightly overstated since the two studies differ on multiple axes beyond tissue (age, strain, dose, modality), making the cross-tissue contrast more tentative than 'surprising.'
• Could briefly note that Receipt 2 investigates resveratrol as a protectant against exercise-induced damage rather than as a performance/benefit enhancer, which is a meaningful framing distinction.

Reviewer note

The memo is a clean, bounded alpha-memo that synthesizes two 2023 mouse studies on resveratrol + exercise training, with the central signal being tissue/endpoint heterogeneity (liver anti-aging effects in mature SAMP8 vs. intestine ferroptosis/inflammation protection in swimming-trained mice). The title and topic align with the cited receipts (resveratrol + exercise training in mice, multiple tissues). The claim is appropriately hedged ('tissue- and endpoint-specific effects that may not extend across organ systems, species, or supplementation contexts') and the caveats section explicitly enumerates the multiple confounders (strain, age, modality, dose, duration). The required falsifier (same-design same-strain tissue comparison) is clearly stated. Source grounding is solid: both citations map to bundle entries with verbatim excerpts and the receipts directly support the bounded tissue-specificity claim. No clinical, policy, or investment recommendations are made. Hedging is appropriate and does not signal weak evidence. Minor polish around the 'surprising' framing and the protectant-vs-enhancer distinction in Receipt 2, but these are style-level, not structural. Accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis